09:41 EDT Avenue Therapeutics trading halted, volatility trading pause
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATXI:
- Avenue Therapeutics Announces Reverse Stock Split
- Avenue Therapeutics announces 1-for-75 reverse stock split
- Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
- Navigating the Maze: Avenue Therapeutics Grapples with Regulatory Hurdles for IV Tramadol
- Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights